FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4375955105> ?p ?o ?g. }

• W4375955105 endingPage "1332" @default.
• W4375955105 startingPage "1325" @default.
• W4375955105 abstract "This study aimed to characterize the influence of a cancer diagnosis on the use of preventive cardiovascular measures in patients with and without cardiovascular disease (CVD).Data from the Behavioural Risk Factor Surveillance System Survey (spanning 2011-22) were used. Multivariable logistic regression models adjusted for potential confounders were applied to calculate average marginal effects (AME), the average difference in the probability of using a given therapy between patients with and without cancer. Outcomes of interest included the use of pharmacological therapies, physical activity, smoking cessation, and post-CVD rehabilitation. Among 5 012 721 respondents, 579 114 reported a history of CVD (coronary disease or stroke), and 842 221 reported a diagnosis of cancer. The association between cancer and the use of pharmacological therapies varied between those with vs. without CVD (P-value for interaction: <0.001). Among patients with CVD, a cancer diagnosis was associated with a lower use of blood pressure-lowering medications {AME: -1.46% [95% confidence interval (CI): -2.19% to -0.73%]}, lipid-lowering medications [AME: -2.34% (95% CI: -4.03% to -0.66%)], and aspirin [AME: -6.05% (95% CI: -8.88% to -3.23%)]. Among patients without CVD, there were no statistically significant differences between patients with and without cancer regarding pharmacological therapies. Additionally, cancer was associated with a significantly lower likelihood of engaging in physical activity in the overall cohort and in using post-CVD rehabilitation regimens, particularly post-stroke rehabilitation.Preventive pharmacological agents are underutilized in those with cancer and concomitant CVD, and physical activity is underutilized in patients with cancer in those with or without CVD.•This paper compared the use of preventive cardiovascular measures, both pharmaceutical and non-pharmaceutical, in patients with and without cancer.•In patients with cardiovascular disease and cancer, there is a lower use of preventive cardiovascular medications compared with those with cardiovascular disease but without cancer. This includes a lower utilization of blood pressure-lowering medications, cholesterol-lowering medications, and aspirin.•Patients with cancer reported lower levels of exercise but higher levels of smoking cessation compared with those without cancer." @default.
• W4375955105 created "2023-05-10" @default.
• W4375955105 creator A5001986733 @default.
• W4375955105 creator A5008844271 @default.
• W4375955105 creator A5010041931 @default.
• W4375955105 creator A5015973780 @default.
• W4375955105 creator A5024753707 @default.
• W4375955105 creator A5040813731 @default.
• W4375955105 creator A5046359837 @default.
• W4375955105 creator A5059805173 @default.
• W4375955105 creator A5064608377 @default.
• W4375955105 creator A5065015589 @default.
• W4375955105 creator A5087164932 @default.
• W4375955105 date "2023-05-09" @default.
• W4375955105 modified "2023-09-28" @default.
• W4375955105 title "The underutilization of preventive cardiovascular measures in patients with cancer: an analysis of the Behavioural Risk Factor Surveillance System, 2011–22" @default.
• W4375955105 cites W1978841947 @default.
• W4375955105 cites W1983640879 @default.
• W4375955105 cites W1996754272 @default.
• W4375955105 cites W2000315796 @default.
• W4375955105 cites W2009989010 @default.
• W4375955105 cites W2037463207 @default.
• W4375955105 cites W2055680524 @default.
• W4375955105 cites W2074151142 @default.
• W4375955105 cites W2082714799 @default.
• W4375955105 cites W2106130415 @default.
• W4375955105 cites W2117943867 @default.
• W4375955105 cites W2159230388 @default.
• W4375955105 cites W2234429503 @default.
• W4375955105 cites W2284819073 @default.
• W4375955105 cites W2298991506 @default.
• W4375955105 cites W2330378155 @default.
• W4375955105 cites W2611265287 @default.
• W4375955105 cites W2620078091 @default.
• W4375955105 cites W2790763997 @default.
• W4375955105 cites W2905160435 @default.
• W4375955105 cites W2922163122 @default.
• W4375955105 cites W2922726768 @default.
• W4375955105 cites W2989626047 @default.
• W4375955105 cites W3007896205 @default.
• W4375955105 cites W3113178943 @default.
• W4375955105 cites W3163953594 @default.
• W4375955105 cites W3167318279 @default.
• W4375955105 cites W3172303672 @default.
• W4375955105 cites W3187826892 @default.
• W4375955105 cites W4200136669 @default.
• W4375955105 cites W4206841660 @default.
• W4375955105 cites W4223527921 @default.
• W4375955105 cites W4225420746 @default.
• W4375955105 cites W4283259168 @default.
• W4375955105 cites W94804449 @default.
• W4375955105 doi "https://doi.org/10.1093/eurjpc/zwad146" @default.
• W4375955105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37158488" @default.
• W4375955105 hasPublicationYear "2023" @default.
• W4375955105 type Work @default.
• W4375955105 citedByCount "1" @default.
• W4375955105 countsByYear W43759551052023 @default.
• W4375955105 crossrefType "journal-article" @default.
• W4375955105 hasAuthorship W4375955105A5001986733 @default.
• W4375955105 hasAuthorship W4375955105A5008844271 @default.
• W4375955105 hasAuthorship W4375955105A5010041931 @default.
• W4375955105 hasAuthorship W4375955105A5015973780 @default.
• W4375955105 hasAuthorship W4375955105A5024753707 @default.
• W4375955105 hasAuthorship W4375955105A5040813731 @default.
• W4375955105 hasAuthorship W4375955105A5046359837 @default.
• W4375955105 hasAuthorship W4375955105A5059805173 @default.
• W4375955105 hasAuthorship W4375955105A5064608377 @default.
• W4375955105 hasAuthorship W4375955105A5065015589 @default.
• W4375955105 hasAuthorship W4375955105A5087164932 @default.
• W4375955105 hasConcept C121608353 @default.
• W4375955105 hasConcept C126322002 @default.
• W4375955105 hasConcept C127413603 @default.
• W4375955105 hasConcept C151956035 @default.
• W4375955105 hasConcept C156957248 @default.
• W4375955105 hasConcept C1862650 @default.
• W4375955105 hasConcept C2777628954 @default.
• W4375955105 hasConcept C2779134260 @default.
• W4375955105 hasConcept C2780645631 @default.
• W4375955105 hasConcept C44249647 @default.
• W4375955105 hasConcept C50440223 @default.
• W4375955105 hasConcept C71924100 @default.
• W4375955105 hasConcept C72563966 @default.
• W4375955105 hasConcept C77350462 @default.
• W4375955105 hasConcept C78519656 @default.
• W4375955105 hasConceptScore W4375955105C121608353 @default.
• W4375955105 hasConceptScore W4375955105C126322002 @default.
• W4375955105 hasConceptScore W4375955105C127413603 @default.
• W4375955105 hasConceptScore W4375955105C151956035 @default.
• W4375955105 hasConceptScore W4375955105C156957248 @default.
• W4375955105 hasConceptScore W4375955105C1862650 @default.
• W4375955105 hasConceptScore W4375955105C2777628954 @default.
• W4375955105 hasConceptScore W4375955105C2779134260 @default.
• W4375955105 hasConceptScore W4375955105C2780645631 @default.
• W4375955105 hasConceptScore W4375955105C44249647 @default.
• W4375955105 hasConceptScore W4375955105C50440223 @default.
• W4375955105 hasConceptScore W4375955105C71924100 @default.
• W4375955105 hasConceptScore W4375955105C72563966 @default.
• W4375955105 hasConceptScore W4375955105C77350462 @default.

• next